Ionis posts Q2 2026 results, flags second-half pipeline milestonesJul 29Quarterly updatedonidalorsenIonis Pharmaceuticals
AstraZeneca and Ionis report Wainua misses primary endpoint in CARDIO-TTRansform Phase IIIJul 9Clinical readoutAstraZenecaeplontersen
Ionis and AstraZeneca's eplontersen misses primary endpoint in Phase 3 ATTR-CM trialJul 9Clinical readoutAstraZenecaeplontersen
Sign inSign in